Please note: Authors from the Paul-Ehrlich-Institut are highlighted in bold. For online abstracts or full text publications, please follow the links.
Ebenig A, Lange MV, Gellhorn Serra M, Kupke A, Plesker R, Qu B, Brown RJP, Maier TJ, Mühlebach MD (2025): Differential efficacy of first licensed western vaccines protecting without immunopathogenesis Wuhan-1-challenged hamsters from severe COVID-19.
NPJ Vaccines 10: 51.
Text
Fischer D, Thies F, Awad O, Brat C, Meybohm P, Baer PC, Müller MM, Urbschat A, Maier TJ, Zacharowski K, Roos J (2023): Red Blood Cell-Derived Microparticles Exert No Cancer Promoting Effects on Colorectal Cancer Cells In Vitro.
Int J Mol Sci 23: 9323.
Text
Hein S, Sabino C, Benz NI, Görgülü E, Maier TJ, Oberle D, Hildt E (2023): The fourth vaccination with a non-SARS-CoV-2 variant adapted vaccine fails to increase the breadth of the humoral immune response.
Sci Rep 13: 10820.
Text
Hastert FD, Hein S, von Rhein C, Benz NI, Husria Y, Oberle D, Maier TJ, Hildt E, Schnierle BS (2022): The SARS-CoV-2 Variant Omicron Is Able to Escape Vaccine-Induced Humoral Immune Responses, but Is Counteracted by Booster Vaccination.
Vaccines (Basel) 10: 794.
Text
Hein S, Mhedhbi I, Zahn T, Sabino C, Benz NI, Husria Y, Renelt PM, Braun F, Oberle D, Maier TJ, Hildt C, Hildt E (2022): Quantitative and Qualitative Difference in Antibody Response against Omicron and Ancestral SARS‐CoV‐2 after Third and Fourth Vaccination.
Vaccines (Basel) 10: 796.
Text
Kahnt AS, Angioni C, Göbel T, Hofmann B, Roos J, Steinbrink SD, Rörsch F, Thomas D, Geisslinger G, Zacharowski K, Grösch S, Steinhilber D, Maier TJ (2022): Inhibitors of Human 5-Lipoxygenase Potently Interfere With Prostaglandin Transport.
Front Pharmacol 12: 782584.
Text
Scheiblauer H, Nübling CM, Wolf T, Khodamoradi Y, Bellinghausen C, Sonntagbauer M, Esser-Nobis K, Filomena A, Mahler V, Maier TJ, Stephan C (2022): Antibody response to SARS-CoV-2 for more than one year − kinetics and persistence of detection are predominantly determined by avidity progression and test design.
J Clin Virol 146: 105052.
Text
Zahn T, Mhedhbi I, Hein S, Raupach J, Miskey C, Husria Y, Bayanga K, Bartel D, Vieths S, Ivics Z, Oberle D, Keller-Stanislawski K, Herrlein ML, Maier TJ, Hildt E (2022): Persistence of infectious SARS-CoV-2 particles for up to 37 days in patients with mild COVID-19.
Allergy 77: 2053-2066.
Online-Abstract
Hassan M, Krieg SC, Ndefo Nde C, Roos J, Maier TJ, El Rady EA, Raslan MA, Sadek KU, Manolikakes G (2021): Streamlined One-Pot Synthesis of Nitro Fatty Acids.
Eur JOC 2021: 2239-2252.
Text
Hellmuth N, Brat C, Awad O, George S, Kahnt A, Bauer T, Huynh Phuoc HP, Steinhilber D, Angioni C, Hassan M, Hock KJ, Manolikakes G, Zacharowski K, Roos J, Maier TJ (2021): Structural Modifications Yield Novel Insights Into the Intriguing Pharmacodynamic Potential of Anti-inflammatory Nitro-Fatty Acids.
Front Pharmacol 12: 715076.
Text
Theuerkauf SA, Michels A, Riechert V, Maier TJ, Flory E, Cichutek K, Buchholz CJ (2021): Quantitative Assays Reveal Cell Fusion at Minimal Levels of SARS-CoV-2 Spike Protein and Fusion-from-Without.
iScience 24: 102170.
Online-Abstract
Iannuzzi F, Sirabella R, Canu N, Maier TJ, Annunziato L, Matrone C (2020): Fyn Tyrosine Kinase Elicits Amyloid Precursor Protein Tyr682 Phosphorylation in Neurons from Alzheimer's Disease Patients.
Cells 9: E1807.
Online-Abstract
Piesche M, Roos J, Kühn B, Fettel J, Hellmuth N, Brat C, Maucher IV, Awad O, Matrone C, Comerma Steffensen SG, Manolikakes G, Heinicke U, Zacharowski KD, Steinhilber D, Maier TJ (2020): The Emerging Therapeutic Potential of Nitro Fatty Acids and Other Michael Acceptor-Containing Drugs for the Treatment of Inflammation and Cancer.
Front Pharmacol 11: 1297.
Text
